Publications by authors named "Lee Baylis"

Claim this Profile
B
Burden of eosinophilic granulomatosis with polyangiitis in Europe.
Rupert W Jakes, Namhee Kwon, Lynn Huynh, Jeremiah Hwee, Lee Baylis

ERJ Open Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics.
David R W Jayne, Benjamin Terrier, Bernhard Hellmich, Paneez Khoury, Lee Baylis

ERJ Open Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype.
Benjamin Terrier, David R W Jayne, Bernhard Hellmich, Jane H Bentley, Jonathan Steinfeld, Lee Baylis

ACR Open Rheumatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypereosinophilic syndrome in Europe: Retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization.
Jeremiah Hwee, Lynn Huynh, Shawn Du, Namhee Kwon, Rupert W Jakes, Lee Baylis

Ann Allergy Asthma Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.
Michael E Wechsler, Bernhard Hellmich, Maria C Cid, David Jayne, Xinping Tian, Lee Baylis

J Allergy Clin Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases.
Mary Jo Strobel, Debbie Alves, Florence Roufosse, Zeina Antoun, Namhee Kwon, Lee Baylis

J Patient Exp· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy.
Chad Moretz, Ashley L Cole, George Mu, Benjamin Wu, Amy Guisinger, Lee Baylis

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab.
Gema Requena, Florence Roufosse, Lee D Baylis, Jonathan Steinfeld

Respirol Case Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis